Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, ro462005 and bosentan in the heart

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 455-462

  Peter, Markus G ^a   Davenport, Anthony P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

50235; Bosentan; BQ123; BQ3020; BQ788; ET(A) and ET(B); FR139317; Left ventricle; Ro462005; Ro470203

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; BOSENTAN; COMPOUND 50235; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; IODINE 125; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; SWINE;

EID: 0030020431     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15212.x     Document Type: Article

References (59)

1. ADACHl, M., YANG, Y.Y., FURUICHI, Y. & MIYAMOTO, C. (1991). Cloning and characterization of cDNA encoding human A-type endothelin receptor. Biochem. Biophys. Res. Commun., 180, 1265-1272.
2. ARAI, H., NAKAU, K., TAKAYA, K., HOSODA, K., OGAWA, Y., NAKANISHI, S. & IMURA, H. (1993). The human endothelin-B receptor gene: structural organization and chromosomal assignment. J. Biol. Chem., 268, 3463-3470.
3. ARAMORI, I., NIREI, H., SHOUBO, M. et al., (1992). Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol. Pharmacol., 43, 127-131.
4. BAX, W.A., BRUlNVELS, A.T., VAN SUYLEN, R.-J., SAXENA, P.R. & HOYER, D. (1993). Endothelin receptors in the human coronary artery, ventricle and atrium. Naunyn Schmied. Arch. Pharmacol., 348, 403-410.
5. BOLGER, G.T., UARD, F., KROGSRUD, R., THIBEAULT, D. & JARAMILLO, J. (1990). Tissue specificity of endothelin binding sites. J. Cardiovasc. Pharmacol., 16, 367-375.
6. BRODDE, O.-E., BALS, S., BROEDE, A., KUNDE, K., SCHÄFER, E. & ZERKOWSKI, H-R. (1992). Receptor systems mediating positive inotropic effect in isolated human right atrium. Br. J. Pharmacol., 105, 108P.
7. CLOZEL, M., BREU, V., BURRI, K., CASSAL, J.-M., FISCHLI, W., GRAY, G.A., HIRTH, G., LOEFFLER, B.-M., MUELLER, M., NEIDHART, W. & RAMUZ, H. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature, 365, 759-761.
8. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LÖFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MÜLLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
9. A receptors. Br. J. Pharmacol., 111, 4-6.
10. A receptors in humans? Trends PharmacoL Sci., 15, 9-11.
11. DAVENPORT, A.P. & MAGUIRE, J.J. (1994b). Endothelin-induced vasoconstriction is mediated by ETA receptors in man. Trends PharmacoL Sci., 15, 136-137.
12. B receptor subtypes in human cardiac ventricle and rat cerebellum. Br. J. Pharmacol., 107, 304P.
13. DAVENPORT, A.P., MORTON. A.J. & BROWN, M.J. (1991). Localization of endothelin-1 (ET-1), ET-2, and ET-3, mouse VIC, and sarafotoxin S6b binding sites in mammalian heart and kidney. J. Cardiovasc. Pharmacol., 17 (Suppl. 7), S152-S155.
14. 125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. J. Cardiovasc. Pharmacol., 13 (Suppl. 5), S166-S170.
15. A sub-type. Br. J. Pharmacol., 114, 1110-1116.
16. B receptor in human vascular smooth muscle. J. Cardiovasc. Pharmacol., 22 (Suppl. 8) S22-S25.
17. ELSHOURBAGY, N.A., LEE, J.L., KORMAN, D.R., NUTHALAGANTI, P., SYLVESTER, D.R., DILELLA, A.G., SUTHIPONG, J.A. & KUMAR, C.S. (1992). Molecular cloning and characterization of the major endothelin receptor subtype in porcine cerebellum. Mol. Pharmacol., 41, 465-473.
18. KUJIMOTO, M., MIHARA, S., NAKAJIMA, S., UEDA, M., NAKAMURA, M. & SAKURAI, K. (1992). A novel non-peptide endothelin antagonist isolated from bayberry, Myrica cerifera. FEBS Letts., 305, 41-44.
19. FUKURODA, T., OZAKI, S., IHARA, M., ISHIKAWA, K., YANO, M. & NISHIKIBE, M. (1994). Synergistic inhibition by BQ-123 and BQ-788 of endothelin-1-induced contractions of the rabbit pulmonary artery. Br. J. Pharmacol., 113, 336-338.
20. 11,15]Ac-endothelin-1(6-21) in conscious rats. Br. J. Pharmacol., 112, 477-486.
21. GODFRAIND, T. (1993). Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br. J. Pharmacol., 110, 1201-1205.
22. A receptor antagonist, BQ123, blocks the vasoconstriction induced by sarafotoxin 6b in the heart but not in other vascular beds. Gen. Pharmacol., 26, 183-193.
23. B by transfected baby hamster kidney cells. Biochem. Biophys. Res. Commun., 194, 1305-1310.
24. HÉMSEN, A., FRANCO-CERECEDA, A., MATRAN, R., RUDEHILL, A. & LUNDBERG, J.M. (1990). Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue. Eur. J. Pharmacol., 191, 319-328.
25. HOWARD, P.G., PLUMPTON, C. & DAVENPORT, A.P. (1992). Anatomical localisation and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J. Hypertens., 10, 1379-1386.
26. A receptor. Life Sci., 50, 247-255.
27. B) receptors. Life Sci., 51, PL47-PL52.
28. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMl, T., OZAKI, S , NAGASE, T., NISHIKIBE, M. & YANO, M. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A., 91, 4892-4896.
29. ISHIKAWA, T., YANAGISAWA, M., KIMURA, S., GOTO, K. & MASAKI, T. (1988). Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am. J. Physiol., 255, H970-H973.
30. B in human kidney. Kidney Intern., 44, 36-42.
31. KATWA, L.C., GUARDA, E. & WEBER, K.T. (1993). Endothelin receptors in cultured adult rat cardiac fibroblasts. Cardiovasc. Res., 27, 2125-2129.
32. B. Biochem. Biophys. Res. Commun., 200, 1708-1712.
33. KITAYOSHI, T., WATANABE, T. & SHIMAMOTO, N. (1989). Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo. Eur. J. Pharmacol., 166, 519-522.
34. LI, J.S., LARIVIERE, R. & SCHIFFRIN, E.L. (1994). Effect of a nonselective endothelin antagonist on vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats: Evidence for a role of endothelin in vascular hypertrophy. Hypertension, 24, 183-188.
35. A receptor mediated constrictor responses to endothelin peptides in human blood vessels in vitro, Br. J. Pharmacol., 115, 191-197.
36. 125I]-ET-1 binding sites and as antagonists of ET-1 vasoconstriction. Br. J. Pharmacol, 113, 157P.
37. 125I]-S6b binding with nanomolar affinity but is a more potent antagonist of S6b vasoconstriction in human blood vessels. Br. J. Pharmacol., 114, 75P.
38. MCPHERSON, G.A. (1983). A practical computer based approach to the analysis of radioligand binding experiments. Comput. Methods. Program. Biomed., 17, 107-114.
39. A receptor-specific effect of 50-235, a nonpeptide endothelin antagonist. Eur. J. Pharmacol., 246, 33-38.
40. MOLENAAR, P., O'REILLY, G., SHARKEY, A., KUC, R.E., HARDING, D.P., PLUMPTON, C., GRESHAM, G.A. & DAVENPORT, A.P. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ. Res., 72, 526-538.
41. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerised approach for the characterisation of ligand bindings systems. Anal. Biochem., 107, 220-239.
42. 125I]IRL-1026, a potent agonist specific for endothelin-B receptors. J. Pharmacol. Exp. Ther., 268, 202-207.
43. 125I]-PD151242. Br. J. Pharmacol., 113, 156P.
44. OGAWA, Y., NAKAO, K., ARAI, H., NAKAGAWAA, O., HOSODA, K., SUGA, S.I., NAKANISHI, S. & IMURA, H. (1991). Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem. Biophys. Res. Commun., 178, 248-255.
45. OPGAARD, O.S., ADNBR, M., GULBENKIAN, S. & EDVINSSON, L. (1994). Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J. Cardiovasc. Pharmacol., 23, 576-583.
46. B-selective antagonist IRL1038 in human tissue. Br. J. Pharmacol., 112, 122P.
47. A-receptors in the heart. Br. J. Pharmacol., 114, 297-302.
48. PLUMPTON, C., CHAMPENEY, R., ASHBY, M.J., KUC, R.E. & DAVENPORT, A.P. (1993). Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J. Cardiovasc. Pharmacol., 22 (Suppl. 8), S26-S28.
49. 2+ and contractility in single ventricular myocytes from the ferret and human. Eur. J. Pharmacol., 214, 293-296.
50. REYNOLDS, E.E., HWANG, O., FLYNN, M.A., WELCH, M.W., CODY, W.L., STEINBAUGH, B., HE, J.X., CHUNG, F.-Z. & DOHERTY, A.M. (1995). Pharmacological differences between rat and human endothelin B receptors. Biochem. Biophys. Res. Commun., 209, 506-512.
51. B antagonist. Br. J. Pharmacol., 113, 869-876.
52. B agonistic activity. Biochem. Biophys. Res. Commun., 179, 286-292.
53. B-selective agonists. J. Biol. Chem., 268, 8547-8553.
54. SCHOMISCH MORAVEC, C., REYNOLDS, E.E., STEWART, R.W. & BOND, M. (1989). Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun., 159, 14-18.
55. TEERLINK, J.R., LOFFLER, B.M., HESS, P., MAIRE, J.P., CLOZEL, M. & CLOZEL, J.P. (1994). Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: Acute effects of the endothelin receptor antagonist Ro47-0203 (bosentan). Circ., 90, 2510-2518.
56. B receptor in endothelial cells. J. Biol. Chem., 269, 2177-21785.
57. 15]-ET-1(11-21). FEBS Letts, 311, 12-16.
58. URADE, Y., FUJITANI, Y., ODA, K., WATAKABE, T., UMEMURA, I., TAKAI, M., OKADA, T., SAKATA, K. & KARAKI, H. (1994). Retraction concerning an cndothclin B receptor-selective antagonist. FEBS Letts, 342, 103.
59. WEBB, M.L., DICKINSON, K.E.J., DELANEY, C.L., LIU, E.C.-K., SERAFINO, R., COHEN, R.B., MONSHIZADEGAN, H. & MORELAND, S. (1992). The endothelin receptor antagonist, BQ123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochem. Biophys. Res. Commun., 195, 887-892.